As global health systems continue to advance toward more resilient and sustainable models, DCVMN was honoured to join the conversation at the Pharma Connect Congress by CPHI, where DCVMN CEO, Rajinder Suri participated alongside 50,000 delegates from 120 countries in discussions shaping the future of pharma and biopharma manufacturing.
Mr. Suri joined industry leaders in the Inaugural lamp-lighting and ribbon-cutting ceremony, celebrating India’s leadership in innovation, sustainability, and digital transformation that are shaping its projected USD 450 billion pharma market by 2030.
He later joined the first session, “Leadership Panel: Reimagining Innovation and Manufacturing to Enable Transformative & Affordable Medicines,” where his insightful remarks resonated strongly with audiences. He emphasized how the world often focuses more on disease than on health, an important reminder that both vaccine and pharma sectors are ultimately working toward the same goal: improving and protecting lives.
Panel discussions underscored the sector’s ongoing transition from generics to innovation, enabled by regulatory reform, accelerated timelines, and stronger government support for manufacturing and R&D. Speakers highlighted the importance of value-driven innovation, while also addressing critical topics such as rare diseases, clinical partnerships, formulation development, and strengthening global manufacturing capacity.
It was also encouraging to see AI and Net-Zero commitments take centre stage, priorities that deeply align with DCVMN’s own strategic focus. AI was recognized as a crucial driver for improved efficiency and quality in manufacturing, with a strong call for validated datasets, regulatory-aligned tools, and adequate funding. Sustainability discussions reinforced the need for carbon management, renewable energy, water balance, green manufacturing, and responsible supply chains to meet global net-zero goals.
As DCVMN continues to champion local vaccine manufacturing and strengthen health security worldwide, we are proud to contribute to global conversations shaping a more sustainable, innovative, and equitable future for all.
